Other
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value
Analysis
StatementIncome Statement
SectionOther
CategoryEfficiency
SignalContext dependent
VolatilityModerate
First reportedQ1 2025
Last reportedQ1 2026Apr 28, 2026
How to read this metric
Higher values reflect more generous long-term incentive compensation or higher stock prices at the time of grant, impacting total compensation expense.
Detailed definition
This metric tracks the weighted-average grant date fair value of equity-based awards, excluding stock options, that have...
Peer comparison
Commonly reported by public companies under GAAP to disclose executive and employee compensation structures.
Metric ID:
other_share_based_compensation_arrangement_by_share_base_a5406bHistorical Data
4 periods
| Q1 '25 | Q2 '25 | Q3 '25 | Q1 '26 | |
|---|---|---|---|---|
| Value | $86.77 | $0.00 | $0.00 | $100.50 |
| QoQ Change | — | -100.0% | — | — |
| YoY Change | — | — | — | +15.8% |
Range$0.00 – $100.50
Avg YoY Growth+15.8%
Median YoY Growth+15.8%
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value at Other Companies
Frequently Asked Questions
- What is Xylem's share based compensation arrangement by share based payment award equity instruments other than options vested in period weighted average grant date fair value?
- Xylem (XYL) reported share based compensation arrangement by share based payment award equity instruments other than options vested in period weighted average grant date fair value of $100.50 in Q1 2026.
- What does share based compensation arrangement by share based payment award equity instruments other than options vested in period weighted average grant date fair value mean?
- The average fair value at the time of grant for equity awards that vested during the period.